Skip to Content

Diphtheria toxoid / pertussis, acellular / tetanus toxoid Pregnancy and Breastfeeding Warnings

Diphtheria toxoid / pertussis, acellular / tetanus toxoid is also known as: Adacel (Tdap), Boostrix (Tdap)

Medically reviewed on Aug 20, 2018

Diphtheria toxoid / pertussis, acellular / tetanus toxoid Pregnancy Warnings

Diphtheria/pertussis, acellular/tetanus has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of adverse effects on embryo-fetal development. There are no controlled data in human pregnancy. Diphtheria/pertussis, acellular/tetanus is only recommended for use during pregnancy when benefit outweighs risk.

A BOOSTRIX Pregnancy Registry has been established to monitor maternal-fetal outcome of vaccine exposures during pregnancy. To register patients, physicians may call 888-452-9622 (USA).

See references

Diphtheria toxoid / pertussis, acellular / tetanus toxoid Breastfeeding Warnings

There are no data on the excretion of diphtheria/pertussis, acellular/tetanus in human milk. The manufacturer recommends that caution be used when administering diphtheria/pertussis, acellular/tetanus to nursing women.

See references

References for pregnancy information

  1. "Product Information. Adacel (diphtheria/pertussis, acel/tetanus adult)." Aventis Pasteur Inc, Swiftwater, PA.

References for breastfeeding information

  1. "Product Information. Adacel (diphtheria/pertussis, acel/tetanus adult)." Aventis Pasteur Inc, Swiftwater, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide